Reportedly offering improved delineation of pulmonary structures and greater accuracy with computed tomography (CT) values of pulmonary tissue, the artificial intelligence (AI)-powered LungQ 3.0.0. may facilitate enhanced precision and efficiency with interventional procedures such as lung volume reduction and ablation procedures.
The Food and Drug Administration (FDA) has granted 510(k) clearance for LungQ 3.0.0., an updated version of an artificial intelligence (AI)-enabled software platform for lung computed tomography (CT) scans, which is currently being utilized in more than 600 hospitals.
The enhanced software provides improved visualization and assessment of a variety of structures including lobes, subsegments and the most peripheral locations in the lungs to facilitate diagnosis and appropriate treatment of conditions such as emphysema and COVID-19, according to Thirona, the developer of LungQ 3.0.0.
The LungQ 3.0.0. software platform provides improved visualization and assessment of a variety of lung structures to facilitate improved outcomes with interventional lung procedures in addition to diagnosis and appropriate management of conditions such as emphysema and COVID-19, according to Thirona, the developer of the software.
Noting that the LungQ software platform has been validated in more than 200 publications globally, Thirona said the LungQ 3.0.0. software enhances the precision and efficiency of interventional procedures ranging from lung segmentectomy and ablation procedures to lung cancer biopsies and lung volume reduction.
“A clearer understanding of lung anatomy helps enable broader adoption of minimally invasive treatments for lung diseases such as COPD and lung cancer, helping save more healthy lung tissue and lung function capacity. … Solutions like LungQ are helping usher in a new era of personalized treatment for lung patients, enabling clinicians all over the world to conduct more advanced, easier-to-perform and less invasive procedures with full confidence,” said Eva van Rikxoort, the founder and CEO of Thirona.
GE HealthCare Debuts AI-Powered Cardiac CT Device at ACC Conference
April 1st 2025Featuring enhanced low-dose image quality with motion-free images, the Revolution Vibe CT system reportedly facilitates improved diagnostic clarity for patients with conditions ranging from in-stent restenosis to atrial fibrillation.
New Collaboration Offers Promise of Automating Prior Authorizations in Radiology with AI
March 26th 2025In addition to a variety of tools to promote radiology workflow efficiencies, the integration of the Gravity AI tools into the PowerServer RIS platform may reduce time-consuming prior authorizations to minutes for completion.